Amy is a medicinal chemist whose research involves the design and synthesis of new drug candidates. Her recent work in the pharmaceutical industry has included the investigation of new treatments for psychiatric and neurodegenerative disorders, including schizophrenia and Alzheimer’s disease. She’s currently undertaking new collaborative research projects to address neglected tropical diseases such as African sleeping sickness and malaria.